NCT01308424View on ClinicalTrials.gov

Safety and Efficacy Study of a New Treatment for Recurrent Symptoms of Oral Herpes Virus Infection

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

171

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

October 31, 2012

Study Completion Date

November 30, 2012

Conditions
Oral Herpes Simplex
Interventions
DRUG

BTL TML HSV

Sublingual micro-dosing for 7 days

DRUG

Matching placebo

sublingual dosing for 7 days

Trial Locations (4)

13815

Family Dentistry, Norwich

14214

School of Dental Medicine, University at Buffalo, Buffalo

15261

University of Pittsburgh School of Dental Medicine, Pittsburgh

40536

University of Kentucky College of Dentistry/Center for Oral Health Research, Lexington

Sponsors
All Listed Sponsors
collaborator

Norwich Clinical Research Associates Ltd.

OTHER

lead

Beech Tree Labs, Inc.

INDUSTRY